Belvedere Trading
BLUE

Belvedere Trading’s bluebird bio BLUE Stock Holding History

Belvedere Trading’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5
Closed -$138 – 717
2023
Q4 		$138 Buy
+5
New +$305 ﹤0.01% 786
2023
Q1 		– Sell
-5,775
Closed -$799K – 963
2022
Q4 		$799K Buy
+5,775
New +$814K ﹤0.01% 76

Other funds holding BLUE

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Belvedere Trading's BLUE Position: Q1 2024 in Review

Belvedere Trading sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 86 shares — an estimated $2.36K sold.

Belvedere Trading first reported a position in BLUE in Q1 2022 and held it in 5 quarters. The position peaked at $646K in Q3 2022. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • Belvedere Trading reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
  • Belvedere Trading sold 86 bluebird bio shares in Q1 2024, an estimated $2.36K.
  • Belvedere Trading first reported a position in bluebird bio in Q1 2022 and held it in 5 quarters.
  • Belvedere Trading's bluebird bio position peaked at $646K in Q3 2022.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on Belvedere Trading's 13F filing for Q1 2024, filed 9 May 2024.